<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">In summary, our findings indicate that data deriving from a large cohort of de-novo PD patients monitored longitudinally are useful in understanding the composite aspects involved in the progression of disease. Our results highlight the role of several factors in determining dyskinesia, thus providing useful information for future design of both biomarker studies and randomized clinical trials.</p>
